Biostar Pharmaceuticals Stock Price Patterns
As of now the relative strength index (rsi) of Biostar Pharmaceuticals' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Biostar Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Biostar Pharmaceuticals and does not consider all of the tangible or intangible factors available from Biostar Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Biostar Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Check out Biostar Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Biostar Pharmaceuticals hype-based prediction, you can estimate the value of Biostar Pharmaceuticals from the perspective of Biostar Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biostar Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Biostar because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biostar Pharmaceuticals after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biostar |
Biostar Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Biostar Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biostar Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Biostar Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biostar Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Biostar Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biostar Pharmaceuticals' historical news coverage. Biostar Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 12.60, respectively. We have considered Biostar Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biostar Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Biostar Pharmaceuticals is based on 3 months time horizon.
Biostar Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Biostar Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biostar Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biostar Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.59 | 12.60 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.00 | 0.00 | 0.00 |
|
Biostar Pharmaceuticals Hype Timeline
Biostar Pharmaceuticals is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biostar is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -1.59%. %. The volatility of related hype on Biostar Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book (P/B) ratio of 0.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biostar Pharmaceuticals had not issued any dividends in recent years. The entity had 1:7 split on the 5th of February 2016. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Biostar Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Biostar Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Biostar Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Biostar Pharmaceuticals' future price movements. Getting to know how Biostar Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biostar Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CWWBF | Plant Based Investment Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CRFTF | BC Craft Supply | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PEMTF | Thoughtful Brands | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOCQ | Biocept | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 1,995 | |
| VRCI | Verde Science | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CLVR | Clever Leaves Holdings | 0.00 | 0 per month | 0.00 | 0.16 | 50.00 | 0.00 | 21,999 | |
| HTGMQ | HTG Molecular Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ELOX | Eloxx Pharmaceuticals | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NMSCA | Nutrition Management Services | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NBRVF | Nabriva Therapeutics Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Biostar Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Biostar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biostar using various technical indicators. When you analyze Biostar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biostar Pharmaceuticals Predictive Indicators
The successful prediction of Biostar Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biostar Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biostar Pharmaceuticals based on analysis of Biostar Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biostar Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biostar Pharmaceuticals's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Biostar Pink Sheet
Biostar Pharmaceuticals financial ratios help investors to determine whether Biostar Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostar with respect to the benefits of owning Biostar Pharmaceuticals security.